Table 2.
Descriptive statistics for the parameters of retinal vessel density, FAZ, and retinal thickness (patients with DCM compared to control).
| Variable | Study Group | M | SD | 95% CI | Range | p |
|---|---|---|---|---|---|---|
| FAZ | Control Group | 0.24 | 0.09 | 0.21–0.28 | 0.087–0.445 | 0.2 |
| DCM Group | 0.27 | 0.07 | 0.24–0.3 | 0.138–0.4795 | ||
| wsVD | Control Group | 49.83 | 1.32 | 49.33–50.32 | 47.65–53.15 | <0.05 |
| DCM Group | 46.2 | 2.24 | 45.36–47.04 | 41.95–52.2 | ||
| fsVD | Control Group | 24.15 | 5.18 | 22.21–26.08 | 15.4–35.5 | |
| DCM Group | 18.07 | 5.09 | 16.16–19.97 | 9.35–27.3 | ||
| psVD | Control Group | 52.51 | 1.25 | 52.04–52.97 | 50.15–54.7 | |
| DCM Group | 49.24 | 2.5 | 48.31–50.18 | 43.7–55.75 | ||
| WT | Control Group | 323.55 | 13.16 | 318.64–328.46 | 294–342 | |
| DCM Group | 311.03 | 14.74 | 305.53–316.54 | 281.5–334 | ||
| FT | Control Group | 256.98 | 18.46 | 250.09–263.88 | 222.5–296.5 | |
| DCM Group | 244.57 | 15.56 | 238.76–250.38 | 221–285.5 | ||
| PFT | Control Group | 332.02 | 15.98 | 326.05–337.99 | 291–354.5 | |
| DCM Group | 320.63 | 15.19 | 314.96–326.31 | 292–344 | ||
| wdPD | Control Group | 50.04 | 3.71 | 48.65–51.42 | 41.05–56.1 | 0.55 |
| DCM Group | 49.7 | 2.98 | 48.58–50.81 | 44.8–54.4 | ||
| fdVD | Control Group | 36.62 | 5.36 | 34.61–38.62 | 24.9–45.6 | 0.08 |
| DCM Group | 33.94 | 5.37 | 31.93–35.95 | 18.95–41.35 | ||
| pdVD | Control Group | 51.85 | 3.79 | 50.44–53.27 | 42.1–58.55 | 0.79 |
| DCM Group | 52.13 | 3.11 | 50.97–53.29 | 46.15–56.85 |
M, mean; SD, standard deviation; CI, confidence interval; FAZ, foveal avascular zone; wsVD, whole vessel density in superficial capillary plexus; fsVD, foveal vessel density in superficial capillary plexus; pdVD, parafoveal vessel density in superficial capillary plexus; WT, whole thickness; FT, foveal thickness; PFT, parafoveal thickness; wdPD, whole vessel density in deep capillary plexus; fdVP, foveal vessel density in deep capillary plexus; pdVD, parafoveal vessel density in deep capillary plexus.